161 results

• FDA Requires New Vision Loss Warnings for Ozempic, Wegovy and Other GLP-1s Over NAION Risk

  November 9, 2026

  Irvin Jackson

  Federal regulators are requiring all GLP-1 medications to carry new label warnings indicating the side effects could put patients at risk of sudden and permanent vision loss.

• GLP-1 Vision Loss Lawsuit Alleges Ozempic Caused Man to Become Legally Blind

  October 13, 2026

  Michael Adams

  A Florida man’s lawsuit claims he became legally blind after developing NAION while using the diabetes drug Ozempic.

• Lawsuit Blames Mounjaro, Ozempic Side Effects for Vision Loss

  September 15, 2026

  Irvin Jackson

  A Louisiana man's lawsuit alleges several months of Mounjaro and Ozempic injections led to vision loss in his right eye.

• Ozempic NAION Lawsuit Filed Over Sudden, Permanent Vision Loss

  August 3, 2026

  Irvin Jackson

  A woman's Ozempic NAION lawsuit claims Novo Nordisk knew the GLP-1 drug carried a risk of vision loss, but refused to provide adequate label warnings.

• GLP-1 Dementia, Alzheimer’s Disease Risks Questioned in New Study

  April 27, 2026

  Irvin Jackson

  A new study finds cognitive decline in patients taking GLP-1 medications for longer than 10 years, yet researchers say it may be the result of those patients living longer than their peers.

• Wegovy Vision Loss Risks 5 Times Higher Than Ozempic: Study

  March 13, 2026

  Irvin Jackson

  A new study links higher doses of semaglutide, the active ingredient in Ozempic and Wegovy, with increased vision loss risks, with Wegovy carrying five times the risk than Ozempic.

• GLP-1 Gout and Bone Fracture Risks Highlighted in New Studies

  March 10, 2026

  Irvin Jackson

  Two new studies warn that Ozempic, Mounjaro and similar drugs may be linked to increased risks of bone density loss, osteoporosis and gout, particularly in older patients.

• Judge Appoints Attorneys to Leadership Positions in GLP-1 Vision Loss Lawsuits

  February 26, 2026

  Irvin Jackson

  A U.S. District Judge has appointed a group of 16 attorneys to work for the benefit of all plaintiffs with pending federal GLP-1 vision loss lawsuits.

• Study Finds No Link Between Side Effects of GLP-1s and Thyroid Cancer

  February 24, 2026

  Irvin Jackson

  A new report dismisses concerns linking drugs like Ozempic and Mounjaro to increased thyroid cancer risks, despite the drugs carrying a black box warning from the FDA.

• Ozempic, Wegovy NAION Risks Twofold Higher Compared to SGLT2i Drugs: Study

  February 19, 2026

  Irvin Jackson

  Researchers from Veterans' Affairs say that drugs like Ozempic and Wegovy carry double the risk of vision problems than other types of diabetes medications.